Variables | Univariate logistic regression analysis | ||
P value | OR | 95% CI | |
Female | 0.062 | 0.438 | 0.184 to 1.043 |
Age | 0.146 | 1.034 | 0.988 to 1.082 |
Smoking | 0.246 | 1.784 | 0.671 to 4.742 |
Drinking | 0.130 | 2.422 | 0.770 to 7.620 |
Hypertension duration >10 years | 0.005 | 3.250 | 1.361 to 7.763 |
Hyperlipidaemia | 0.825 | 1.153 | 0.327 to 4.059 |
Diabetes | 0.028 | 3.058 | 1.130 to 8.274 |
Coronary artery disease | 0.795 | 0.762 | 0.098 to 5.942 |
Cerebrovascular stenosis | 0.201 | 1.894 | 0.712 to 5.041 |
Ischaemic cerebrovascular disease | 0.409 | 1.855 | 0.517 to 6.655 |
Red cell count | 0.213 | 1.614 | 0.760 to 3.425 |
White cell count | 0.986 | 1.000 | 0.985 to 1.106 |
Platelet count | 0.627 | 1.002 | 0.995 to 1.008 |
APTT | 0.748 | 0.978 | 0.855 to 1.119 |
INR | 0.364 | 3.940 | 0.204 to 76.083 |
Posterior circulation UIA | 0.007 | 3.509 | 1.400 to 8.792 |
Maximum size | 0.320 | 1.032 | 0.969 to 1.100 |
Multiple aneurysms | 0.426 | 1.484 | 0.561 to 3.928 |
Non-saccular aneurysms | 0.082 | 2.544 | 0.887 to 7.295 |
Flow diverters | 0.285 | 1.627 | 0.666 to 3.974 |
LTA | |||
ADP-MPA | <0.001 | 1.066 | 1.031 to 1.102 |
AA-MPA | 0.094 | 1.028 | 0995 to 1.063 |
Metabolic types | |||
Fast metabolisers | 1 | 1 | 1 |
Ultra-fast metabolisers | 0.999 | – | – |
Intermediate metabolisers | 0.212 | 1.898 | 0.695 to 5.187 |
Poor metabolisers (%) | 0.249 | 2.159 | 0.584 to 7.984 |
AA-MPA, maximum platelet aggregation rate induced by arachidonic acid; ADP-MPA, maximum platelet aggregation rate induced by ADP; APTT, activated partial thromboplastin time; INR, international normalised ratio; LTA, light transmission aggregometry; UIA, unruptured intracranial aneurysm.